Cargando…
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
Autores principales: | Labiano, Sara, Palazon, Asis, Bolaños-Mateo, Elixabet, Azpilicueta, Arantza, Rodriguez, Alfonso, Morales-Kastresana, Aizea, Marin, Elena, Gurpide, Alfonso, Rodriguez-Ruiz, Maria, Aznar, M Angela, Jure-Kunkel, Maria, Melero, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292444/ http://dx.doi.org/10.1186/2051-1426-2-S3-P218 |
Ejemplares similares
-
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
por: Bolaños-Mateo, Elixabet, et al.
Publicado: (2014) -
Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013) -
Therapeutic activity of a combination of immunostimulatory monoclonal antibodies (anti-B7-H1, CD137 and OX40) on a c-myc-driven spontaneous transgenic model of hepatocellular carcinoma
por: Morales-Kastresana, Aizea, et al.
Publicado: (2013) -
CD137 (4-1BB) costimulation of CD8(+) T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation
por: Otano, Itziar, et al.
Publicado: (2021) -
Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
por: Glez-Vaz, Javier, et al.
Publicado: (2022)